1 / 1

CONCLUSION

Abstract number: 636. 24hrs. 12hrs. A. B.

Télécharger la présentation

CONCLUSION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Abstract number: 636 24hrs 12hrs A B Novel antitumor quinols: the role of thioredoxinEng-Hui Chew, Jenny C. Cookson, Charles S. Matthews, Ji-Hong Zhang, Thilo Hagen, Tracey D. Bradshaw, Malcolm F.G. Stevens, Andrew D. WestwellCentre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, NG7 2RD, UK Novel antitumor QuinolsAW464 and BW114 exhibit selective antiproliferative activity against colon, renal and breast carcinoma cell lines (GI50 < 0.5 μM). Growth inhibition against renal, colon and breast xenografts has also been demonstrated1, 2. Preliminary results (microarray analysis, insulin reduction assay) suggested that quinols targeta 12 kDa redox-regulating thiol protein thioredoxin (Trx)3. Here we report further evidence of quinols interacting with thioredoxin and the results of investigations into the induction of oxidative stress and apoptosis by quinols. • Quinols induce cellular apoptosis Figure 4: Annexin V-FITC/Propidium Iodide double staining Propidium Iodide • AW464 Binding To Thioredoxin Protein • Quinols induce oxidative stress Figure 1: A, B: Mass spectrum of human Trx Figure 3: A, B: MTT cell viability assays (n=4) Figure 2: ROS production induced by AW464 Annexin V-FITC Reduced Trx HCT116 colon cells treated with AW464 (1 µM) showed an increasing proportion of cells undergoing apoptosis between 12 and 24 hours. Figure 5: Western blot Dose-dependent PARP cleavage and caspase 3 activation was observed in HCT116 cells treated with AW464 and BW114 for 24 hours. Cell Number Campothecin 1 µM, 24hrs (tve ctrl) AW464 BW114 untreated 1 3 6 0.5 1 3 (µM) Reduced Trx + AW464 PARP Cleaved PARP -actin H2DCFDA fluorescence Caspase 3 ROS production was induced in HCT116 colon cells following 7 hours AW464 treatment. Cleaved Caspase 3 Modulation of the glutathione (GSH) system and quinol cytotoxicity. - BSO-induced GSH depletion increased cytotoxicity of quinols by 10-fold (Fig3A). - Supplementation of GSH monoethyl ester caused a 2-fold reduction in potency (Fig3B). -actin No blockade of cytotoxicity by pan caspase inhibitor Z-VAD-FMK and caspase 3 inhibitor Z-DEVD-FMK, suggesting that quinols induce apoptosis via both caspase dependent and independent pathways. (A) Non-drug treated thioredoxin: mass peak 11,606. (B) AW464 treated thioredoxin: mass peaks 12,336, 12,586 and 12,821 corresponding to thioredoxin plus 3, 4 and 5 AW464 molecules respectively. Subsequent MS/MS analysis of trypsin digested peptides showed additional mass of AW464 only at cysteine residues. CONCLUSION We conclude that quinols induce oxidative stress, cellular apoptosis and thioredoxin emerges as a molecular target of these novel antitumor agents. Reference: 1. Wells et al J. Med. Chem. 2003, 46, 532. 2. Berry et al J. Med.Chem. 2005, 48, 639. 3. Bradshaw et al Cancer Res. 2005, 65, 3911.

More Related